
    
      This is a randomised, double-blind, placebo-controlled, two-period crossover study, to
      investigate the efficacy of ONO-8539 on acid-induced oesophageal hypersensitivity in healthy
      male adult volunteers. Each subject will be randomised to ONO-8539 or placebo twice daily in
      the first treatment period and the alternate treatment in the second treatment period. Dosing
      in each period will be for 15 days.
    
  